Hemispherx BioPharma, Inc. (NYSEMKT:HEB)

CAPS Rating: 1 out of 5

A biopharmaceutical company engaged in the clinical development, manufacture, marketing and distribution of new drug entities based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.


Player Avatar pchop123 (80.37) Submitted: 12/5/2012 10:17:44 AM : Underperform Start Price: $0.83 HEB Score: +15.96

market manipulation can only do so much for so long & then "look out below"

Member Avatar dmsrz8 (54.65) Submitted: 12/9/2012 5:58:25 PM
Recs: 0

How can you call a stock under a dollar that waffles up and down by pennies on the dollar manipulated? Considering the upcoming meetings I am surprised it has lost value in the last few weeks. Your comment does not make sense really when you look at where the company stands.

Featured Broker Partners